Business

MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders

Saskatoon, Saskatchewan--(Newsfile Corp. - July 30, 2025) - MustGrow Biologics Corp. (TSXV: MGRO...

articleMustgrow Biologics Corp.July 30, 20253/company/mustgrow-biologics-corp/news/mustgrow-announces-non-brokered-life-offering-of-up-to-dollar3-million-proposed-repricing-of-warrants-and-shares-for-debt-settlement-offer-to-debentureholders
MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders

About this update from Mustgrow Biologics Corp.

[{"type":"text","content":"MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to DebentureholdersSaskatoon, Saskatchewan--(Newsfile Corp. - July 30, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the \"Company\" or \"MustGrow\"), is pleased to announce the following: (i) a non-brokered private placement of up to 4,285,715 units of the Company (each, a \"Unit\") at a price of $0.70 per Unit for gross proceeds of up to $3,000,000 (the \"LIFE Offering\"); (ii) the proposed repricing of outstanding share purchase warrants issued pursuant to its January 16, 2025 private placement (the \"Warrant Repricing\"); and (iii) its intention to offer shares for debt settlement to all holders of unsecured convertible debentures issued pursuant to its January 16, 2025 private placement (the \"Shares for Debenture Debt Settlement\").LIFE OfferingEach Unit will consist of (i) one common share of the Company (a \"Share\"); and (ii) one common share purchase warrant (a \"Warrant\"). Each whole Warrant will be exercisable for a period of 60 months from the Closing Date (defined below) and will entitle the holder thereof to purchase one additional Share (a \"Warrant Share\") at an exercise price of $0.90 per Warrant Share. The Company intends to use the net proceeds raised from the LIFE Offering for inventory production for its mustard-derived organic biofertility product TerraSanteTM, inventory for agricultural products to sell via its Canadian distribution platform NexusBioAg, and working capital and general corporate purposes.Subject to the rules and policies of the TSX Venture Exchange (the \"TSXV\"), the securities issuable from the sale of Units to Canadian resident subscribers will not be subject to a hold period under applicable Canadian securities laws. Insiders and certain consultants that participate in the LIFE Offering would be subject to a four-month hold period pursuant to applicable policies of the TSXV.There is an offering document related to the LIFE Offering that can be accessed under the Company's profile at www.sedarplus.ca and on the Company's website at www.MustGrow.ca. Prospective investors should read this offering document before making an investment decision.It is expected that closing of the LIFE Offering will take place on or about August 2...

More updates from Mustgrow Biologics Corp.